| Literature DB >> 31419480 |
Nikki Kenters1, Martin Kiernan2, Anuradha Chowdhary3, David W Denning4, Javier Pemán5, Katja Saris6, Silke Schelenz7, Ermira Tartari8, Andreas Widmer9, Jacques F Meis10, Andreas Voss11.
Abstract
Candida auris (C. auris) is an emerging fungal pathogen causing invasive infections and outbreaks that have been difficult to control in healthcare facilities worldwide. There is a lack of current evidence for pragmatic infection prevention and control recommendations. The aim of this paper was to review the epidemiology of C. auris and identify best practices with a panel of experts, in order to provide guidance and recommendations for infection prevention and control measures based on available scientific evidence, existing guidelines and expert opinion. The Infection Prevention and Control working group of the International Society of Antimicrobial Chemotherapy organised an expert meeting with infection prevention and mycology experts to review recommendations for healthcare workers on infection prevention and control measures for C. auris at inpatient healthcare facilities. The most common interventions included: screening, standard precautions, cleaning and disinfection, inpatient transfer, outbreak management, decolonisation, and treatment.Entities:
Keywords: Antifungal resistance; Candida auris; Infection prevention and control; International Society of Antimicrobial Chemotherapy; Outbreak; Transmission
Mesh:
Year: 2019 PMID: 31419480 DOI: 10.1016/j.ijantimicag.2019.08.013
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN: 0924-8579 Impact factor: 5.283